Skip to main content
Erschienen in: The journal of nutrition, health & aging 2/2020

09.11.2019

HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate Cancer

verfasst von: Anne-Laure Couderc, X. Muracciole, E. Nouguerede, D. Rey, S. Schneider, P. Champsaur, E. Lechevallier, L. Lalys, P. Villani

Erschienen in: The journal of nutrition, health & aging | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Sarcopenia is a muscle disease defined by a loss of muscle strength associated to a decrease in skeletal muscle mass. In addition to aging, many factors may contribute to sarcopenia as cancer and/or androgen deprivation therapy (ADT).

Objectives

The aims of this study are to describe the prevalence of sarcopenia in older prostate cancer patients before initiation of treatment with ADT and radiotherapy, and to evaluate the impact of ADT on the occurrence or aggravation of sarcopenia in this population.

Design

Longitudinal study.

Participants and setting

Sarcopenia was prospectively evaluated in 31 consecutive patients aged 70 to 88 years, referred in one hospital unit of south eastern France, for a comprehensive geriatric assessment (CGA) before cancer treatment initiation.

Measurements and results

CGA, measures of muscle strength and physical performances were performed at baseline (T0) and at the end of cancer treatment (T1). Appendicular skeletal muscle mass was measured by Dual-energy X-ray absorptiometry (DXA) at the end of treatment. At T0, 8 patients (among 31) had a probable sarcopenia according to European consensus, and 18 had altered physical performance. At T1, 15 patients (among 19) had abnormal one leg balance test. Finally, only one patient had a sarcopenia confirmed by DXA.

Conclusion

This preliminary study showed a high prevalence of muscle disorders before initiation of ADT in a population of elderly cancer prostate patients with intermediate frailty status, and an increased risk of falls at the end of ADT. This highlighted the importance of screening for sarcopenia before treatment initiation, to prevent the occurrence or aggravation of sarcopenia by possible adjustment of treatment, and implementation of appropriate exercise and nutrition interventions.
Literatur
1.
Zurück zum Zitat Rebillard X, Grosclaude P, Leone N, et al. [Incidence and mortality of urological cancers in 2012 in France]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol 2013;23 Suppl 2:S57–65.CrossRef Rebillard X, Grosclaude P, Leone N, et al. [Incidence and mortality of urological cancers in 2012 in France]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol 2013;23 Suppl 2:S57–65.CrossRef
3.
Zurück zum Zitat Hmadi H and Daneshmand S. Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes. Patient Related Outcome Measures 2014;5:63–70. Hmadi H and Daneshmand S. Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes. Patient Related Outcome Measures 2014;5:63–70.
4.
Zurück zum Zitat Mitsuzuka K, Arai Y. Metabolic changes in patients with prostate cancer during androgen deprivation therapy. International Journal of Urology 2018;25:45–53CrossRefPubMed Mitsuzuka K, Arai Y. Metabolic changes in patients with prostate cancer during androgen deprivation therapy. International Journal of Urology 2018;25:45–53CrossRefPubMed
5.
Zurück zum Zitat Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16–31.CrossRefPubMed Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48(1):16–31.CrossRefPubMed
6.
Zurück zum Zitat Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011;12(4):249–56.CrossRefPubMed Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011;12(4):249–56.CrossRefPubMed
7.
Zurück zum Zitat Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15(2):95–101.CrossRefPubMed Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15(2):95–101.CrossRefPubMed
9.
Zurück zum Zitat Friedman PJ, Richmond DE, Baskett JJ. A prospective trial of serial gait speed as a measure of rehabilitation in the elderly. Age Ageing 1988;17(4): 227–235.CrossRefPubMed Friedman PJ, Richmond DE, Baskett JJ. A prospective trial of serial gait speed as a measure of rehabilitation in the elderly. Age Ageing 1988;17(4): 227–235.CrossRefPubMed
10.
Zurück zum Zitat Podsiadlo D, Richardson S. The timed up and go: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39: 142–148.CrossRefPubMed Podsiadlo D, Richardson S. The timed up and go: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39: 142–148.CrossRefPubMed
11.
Zurück zum Zitat Soubeyran P, Bellera C, Goyard J, et al. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study. PloS One 2014;9 (12): e115060.CrossRefPubMedPubMedCentral Soubeyran P, Bellera C, Goyard J, et al. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study. PloS One 2014;9 (12): e115060.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1998;25 (6): 649–655.CrossRef Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1998;25 (6): 649–655.CrossRef
13.
Zurück zum Zitat Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL, a standardized measure of biological and psychological function. JAMA 1963;185: 914–919.CrossRefPubMed Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL, a standardized measure of biological and psychological function. JAMA 1963;185: 914–919.CrossRefPubMed
14.
Zurück zum Zitat Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9: 179–186.CrossRefPubMed Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9: 179–186.CrossRefPubMed
15.
Zurück zum Zitat Vellas BJ, Sharon J, Wayne MS et al. One-Leg Balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc 1997;45 (6):735–738.CrossRefPubMed Vellas BJ, Sharon J, Wayne MS et al. One-Leg Balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc 1997;45 (6):735–738.CrossRefPubMed
16.
Zurück zum Zitat Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002;18(4):737–757.CrossRefPubMed Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002;18(4):737–757.CrossRefPubMed
18.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12: 189–198.PubMed Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12: 189–198.PubMed
19.
Zurück zum Zitat Reijnierse EM, Trappenburg MC, Leter MJ et al. The impact of different diagnostic criteria on the prevalence of sarcopenia in healthy elderly participants and geriatric outpatients. Gerontology 2015;61:491–496.CrossRefPubMed Reijnierse EM, Trappenburg MC, Leter MJ et al. The impact of different diagnostic criteria on the prevalence of sarcopenia in healthy elderly participants and geriatric outpatients. Gerontology 2015;61:491–496.CrossRefPubMed
21.
Zurück zum Zitat Cruz-Jentoft A, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age and Ageing 2014;43: 748–759.CrossRefPubMedPubMedCentral Cruz-Jentoft A, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age and Ageing 2014;43: 748–759.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Shimokata N, Shimada H, Satake S et al. Epidemiology of sarcopenia. Geriatr Gerontol Int 2018;18 (Suppl. 1): 13–22.CrossRefPubMed Shimokata N, Shimada H, Satake S et al. Epidemiology of sarcopenia. Geriatr Gerontol Int 2018;18 (Suppl. 1): 13–22.CrossRefPubMed
23.
Zurück zum Zitat Walston J, Hadley EC, Ferrucci L, et al. Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006;54: 991–1001.CrossRefPubMed Walston J, Hadley EC, Ferrucci L, et al. Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006;54: 991–1001.CrossRefPubMed
24.
Zurück zum Zitat Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sco Med Sci 2001;56: M146–M156.CrossRef Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sco Med Sci 2001;56: M146–M156.CrossRef
25.
Zurück zum Zitat Winters-Stone KM, Moe E, Graff JN et al. Falls and frailty in prostate cancer survivors: current, past, and never users of androgen deprivation therapy. J Am Geriatr Soc 2017;65 (7): 1414–1419.CrossRefPubMedPubMedCentral Winters-Stone KM, Moe E, Graff JN et al. Falls and frailty in prostate cancer survivors: current, past, and never users of androgen deprivation therapy. J Am Geriatr Soc 2017;65 (7): 1414–1419.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Wu FJ, Sheu SY, Lin HC, Chung SD. Increased fall risk in patients receiving androgen deprivation therapy for prostate cancer. Urology 2016;95: 145–150.CrossRefPubMed Wu FJ, Sheu SY, Lin HC, Chung SD. Increased fall risk in patients receiving androgen deprivation therapy for prostate cancer. Urology 2016;95: 145–150.CrossRefPubMed
27.
Zurück zum Zitat Alibhai SMH, Breunis H, Timilshina N, et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol 2010;28:5038–5045.CrossRefPubMed Alibhai SMH, Breunis H, Timilshina N, et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol 2010;28:5038–5045.CrossRefPubMed
28.
30.
Zurück zum Zitat Lester-Coll NH, Goldhaber SZ, Sher DJ, D’Amico AV. Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysis. Cancer 2013;119(10):1808–1815.CrossRefPubMed Lester-Coll NH, Goldhaber SZ, Sher DJ, D’Amico AV. Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysis. Cancer 2013;119(10):1808–1815.CrossRefPubMed
Metadaten
Titel
HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate Cancer
verfasst von
Anne-Laure Couderc
X. Muracciole
E. Nouguerede
D. Rey
S. Schneider
P. Champsaur
E. Lechevallier
L. Lalys
P. Villani
Publikationsdatum
09.11.2019
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 2/2020
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-019-1294-7

Weitere Artikel der Ausgabe 2/2020

The journal of nutrition, health & aging 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.